-
World’s First Dengue Vaccine Now Available in Philippines
The world’s first ever dengue vaccine is now available in the country, and doctors in several private hospitals are providing the vaccine against the potentially deadly dengue virus, the Pediatric Infectious Disease Society of the Philippines (PIDSP) reported yesterday.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
Bharat Biotech Says Working on Two Possible Zika Vaccines
Indian biotechnology company Bharat Biotech said on Wednesday it was working on two possible vaccines to fight the Zika virus, which has been linked to birth defects in thousands of babies in Brazil.
- Categories
- Health Care
-
Sanofi to Work on Zika Vaccine as Health Emergency Declared
Sanofi will work on developing a vaccine against Zika virus, the mosquito-borne pathogen whose explosive spread has touched off a global public health emergency.
- Categories
- Health Care
- Region
- Latin America
-
U.S. Launches ‘Full-court Press’ for a Zika Vaccine
The United States is pushing to develop a vaccine for the Zika virus, a top health official said Thursday, as doctors warn that the mosquito-borne disease, which causes birth defects in infants and is typically found abroad, has become a growing threat in the U.S.
- Categories
- Health Care
- Region
- Latin America
-
Dozens of Drug Makers Agree on Effort to Combat Antibiotic Resistance
In an unprecedented bid to address antibiotic resistance, more than 80 drug and device makers have issued adeclaration urging governments to “support investment” in developing medicines and diagnostic tools to combat drug-resistant infections.
- Categories
- Health Care
-
Vaccines Alliance Signs $5 Million Advance Deal for Merck’s Ebola Shot
The Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
India Waives Large-Scale Clinical Trials for Sanofi’s Dengue Vaccine
An expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine developed by French drug maker Sanofi. The Subject Expert Committee, which advises the Drug Controller General of India, as part of its Jan 12 meeting said it "recommends for market authorization of the vaccine in the age group of 18-45 years only with the condition to conduct Phase IV clinical trial in time bound manner."
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Sanofi Pasteur Provides Key Support to the Human Vaccines Project
Sanofi Pasteur is supporting the Project by providing research funding to oversee, coordinate and conduct the scientific and administrative activities of the Human Vaccines Project Research Program this year. The funds will be used by the Project to launch and execute pilot studies, build partnerships with and across the stakeholder community, and set up the infrastructure and operational support for the Human Vaccines Project Research Program, according to Sanofi.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.